ARS Pharmaceuticals
SPRY
SPRY
97 hedge funds and large institutions have $252M invested in ARS Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
+5
Holders Change %
+5.43%
% of All Funds
1.55%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
23
Increased
38
Reduced
22
Closed
18
Calls
$4.33M
Puts
$3.83M
Net Calls
+$502K
Net Calls Change
-$4.2M
